Second Sight Medical (NSDQ:EYES) said yesterday that it plans to accelerate development and commercialization of its Orion visual cortical prosthesis system and posted first quarter earnings that missed expectations on Wall Street. Sylmar, Calif.-based Second Sight’s Orion is designed to connect the camera in a pair of eyeglasses with an implant that receives the camera signal […]
Second Sight Medical releases early feasibility data on Orion cortical implant
Second Sight Medical (NSDQ:EYES) today announced preliminary results from a small feasibility study of its Orion cortical implant, which is designed to give eyesight to the blind. Sylmar, Calif.-based Second Sight’s Orion is designed to connect the camera in a pair of eyeglasses with an implant that receives the camera signal and translates it to […]
Second Sight Medical closes $35m rights offering
Second Sight Medical (NSDQ:EYES) said today that it closed a $34.6 million rights offering. The Sylmar, Calif.-based company said that it received subscriptions for a total of 45.8 million units, with a final subscription price of 72.4¢ per unit. Second Sight said that entities controlled by board chair Gregg Williams acquired a total of 41.4 million […]
What should the Mann Foundation do next?
Dr. Robert Greenberg, the Mann Foundation’s new executive chairman, has ideas about where to take one of medtech’s top research and development outfits. He explained more at DeviceTalks West in December. The new executive chairman of the Alfred E. Mann Foundation for Scientific Research sees the foundation continuing its mission of developing devices for unmet medical needs. The foundation […]
Second Sight Medical wins final CMS reimbursement nod for Argus II
Second Sight Medical (NSDQ:EYES) said today that the Centers for Medicare & Medicaid Services finalized the outpatient payment rate for its Argus II retinal prosthesis system for the coming year. The Argus II induces visual perception in blind patients with retinitis pigmentosa by stimulating of the retina’s remaining cells with electrical pulses, which allows for the perception […]
Second Sight raises $4m
Second Sight Medical (NSDQ:EYES) said today it raised approximately $4 million in a private placement deal with entities owned by board chair Gregg Williams. The Sylmar, Calif.-based company said that it floated approximately 2.5 million shares of stock at $1.62 per share, which was the last reported sale price of its stock on the effective date. “This […]
Second Sight inks $5m private placement deal
Second Sight Medical (NSDQ:EYES) said today it inked a $5 million private placement deal with funds slated to support continued development and testing of its implantable visual prosthetic technology. The Los Angeles-based company said it is selling approximately 3.2 million shares of common stock at $1.55 per share to entities owned by its board chair Gregg […]
Second Sight shares down despite Q2 earnings beat
Shares in Second Sight Medical (NSDQ:EYES) fell today despite the opthalmalogical device maker beating loss per share expectations on Wall Street with its second quarter earnings results. The Los Angeles-based company posted losses of $8 million, or 12¢ per share, on sales of $1.9 million for the three months ended June 30, seeing losses grow 16.3% […]
Second Sight Medical raises $10m
Second Sight Medical (NSDQ:EYES) said today it inked a stock purchase agreement worth approximately $10 million with businesses owned by board chair Gregg Williams. In the purchase agreement, the Los Angeles-based company said it sold approximately 6.8 million shares of common stock at $1.48 per share. “As chairman of our board, Gregg has provided valuable guidance to […]
Medtronic taps Harvard cardiologist Mauri for clinical research VP | Personnel Moves – April 10, 2018
Medtronic (NYSE:MDT) said last week it tapped Harvard Medical School professor and cardiologist Dr. Laura Mauri as its new vice president of global clinical research and analytics. In the new position, Dr. Mauri will direct dynamic global clinical research strategies as well as the development of novel analytical and data science solutions as the Fridley, Minn.-baesd […]
Second Sight Medical taps Blake as CFO | Personnel Moves – March 27, 2018
Second Sight Medical (NSDQ:EYES) said last week it named John Blake as its new chief financial officer, succeeding Thomas Miller who has held the position since 2014. Before joining Second Sight Medical, Blake acted as finance senior VP at Tyr Pharma, and has held positions with Volcano Corp and BD Biosciences, the company said. Blake worked with […]
MassDevice Network
@MassDevice
LinkedIn
YouTube